Mabwell (Shanghai) Bioscience Co., Ltd. (SHA:688062)
China · Delayed Price · Currency is CNY 38.77
-1.38 (-3.44%)
Apr 17, 2026, 3:00 PM CST
SHA:688062 Market Cap
SHA:688062 has a market cap or net worth of 15.45 billion as of April 17, 2026. Its market cap has increased by 104.85% in one year.
Market Cap
15.45B
Enterprise Value
17.07B
Revenue
662.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
38.77
Market Cap Chart
Since January 18, 2022, SHA:688062's market cap has increased from 9.79B to 15.45B, an increase of 57.77%. That is a compound annual growth rate of 11.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 15.45B | 0.53% |
| Dec 31, 2025 | 15.36B | 90.35% |
| Dec 31, 2024 | 8.07B | -38.21% |
| Dec 29, 2023 | 13.06B | 126.23% |
| Dec 30, 2022 | 5.77B | -41.02% |
| Jan 18, 2022 | 9.79B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anhui Anke Biotechnology (Group) | 16.45B |
| Jinyu Bio-technology | 16.04B |
| Inner Mongolia Furui Medical Science | 15.10B |
| Staidson (Beijing) BioPharmaceuticals | 14.49B |
| Tibet Cheezheng Tibetan Medicine | 13.27B |
| Chengzhi | 12.97B |
| Vcanbio Cell & Gene Engineering Corp., | 12.91B |
| InventisBio | 12.76B |